A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...

The new treatment disrupts overactive renal nerves. Michael Garrity's high blood pressure improved after renal ... But when it stays high — consistently 130 over 80 or higher, according to the most ...

Highlights from three RCC treatment strategy panel discussions focused on biomarkers, combo therapies, toxicity management, and emerging therapeutic targets. Emerging therapies, including LAG-3 ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

The median progression-free survival was 30.3 months, and the median overall survival was not reached. The combination of belzutifan and cabozantinib has demonstrated “promising” antitumor ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...

The study emphasizes the need for further research to make exceptional responses more common in RCC treatment. In patients with RCC, exceptional response to immunotherapy may be related to clonal ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...